Sung-Hwan Cho
Director Ejecutivo en CHOA PHARMACEUTICAL CO., LTD. .
Fortuna: 2 M $ al 31/05/2024
Cargos activos de Sung-Hwan Cho
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CHOA PHARMACEUTICAL CO., LTD. | Director/Miembro de la Junta | 18/02/2002 | - |
Director Ejecutivo | - | - | |
Presidente | - | - | |
Medipharm
Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Director Ejecutivo | - | - |
Presidente | - | - |
Historial de carrera de Sung-Hwan Cho
Formación de Sung-Hwan Cho.
Korea University | Undergraduate Degree |
Chung-Ang University | Graduate Degree |
Estadísticas
Internacional
Corea del Sur | 5 |
Operativa
President | 2 |
Chief Executive Officer | 2 |
Director/Board Member | 1 |
Sectorial
Consumer Services | 3 |
Health Technology | 2 |
Distribution Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
CHOA PHARMACEUTICAL CO., LTD. | Health Technology |
Empresas privadas | 1 |
---|---|
Medipharm
Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Distribution Services |
- Bolsa de valores
- Insiders
- Sung-Hwan Cho
- Experiencia